Clinical Trial Update: High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update concerns high-dose quetiapine for treatment-refractory schizophrenia or schizoaffective disorder, spanning Phase 2 and Phase 3, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Manhattan Psychiatric Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2, Phase 3 | Status: COMPLETED